- Chirurgia del Seno
- Chirurgia delle Ermie
- Diastasi dei Retti
- Incontinenza Fecale
- Incontinenza Urinaria
- Macroplastique
- Mesh
- Microchirurgia
- Prolasso Rettale
- Riparazione del Pavimento Pelvico
- Sling per incontinenza
- Suture mesh
- Urodinamica
Percutaneous posterior tibial nerve stimulation for Voiding Dysfunction
2011 - B. Adile, G.Adile, D. Passalacqua, P. Speciale, M. Vella
Percutaneous posterior tibial nerve stimulation for Voiding Dysfunction
Pregnancy and childbirth, pelvic surgery and some medication (diuretics and anticholinergic), obesity, some neurological disease (Multiple-sclerosis, spinal cord injury, diabetes) are associated with urge incontinence as the long-held clinical impression confirmed. The aim of this study was to evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS) for the treatment of complaints related to overactive bladder syndrome: urinary urgency, urinary frequency, urge incontinence (UI), non- obstructive urinary retention.
Ricostruzione del seno dopo mastectomia
2010 - Paepke S, Niemeyer M, Krol J, Müller D, Machens HG, Kiechle M
Experience with the use of titanized polypropylene mesh (TiLOOP® Bra) in oncoplastic breast surgery
1 Interdisciplinary Breast Center and Gynecological Clinic, Technical University of Munich (TU München)
2 Clinic for Plastic and Reconstructive Surgery, Technical University of Munich (TU München)
Robotically assisted laparoscopic repair of anterior vaginal wall and uterine prolapse by lateral suspension with mesh: initial experience and video
2010
Sacral colpopexy/hysteropexy is a well-established approach to vaginal apex support and was the first technique used to treat pelvic organ prolapse (POP) with robotic assistance. However, dissection at the level of the promontory may be difficult, especially in obese patients, and associated with rare but potential serious morbidity such as life-threatening vascular injury. In an attempt to avoid this risk, we describe a new robotic approach for POP repair with lateral suspension.
Cuff Testing in diagnosing BOO
2010 - S. Banerjee, C. Unwin, V. Srinivasan, H. Toussi
Role of non invasive urodynamics using penile Cuff Testing in diagnosing BOO.
A technique of non invasive Urodynamic study for men has been developed by scientists at Newcastle hospital using penile cuff. It works on the principle of interruption of flow of urine using a cuff around the penis and indirectly measuring the intravescical pressure (P cuff = P urethra = P ves.).
Urology department, Glan Clwyd Hospital, Betsi Cadwaladar University Healt Board
Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow-up
2020 - Maurizio Serati , Marco Soligo , Andrea Braga , Simona Cantaluppi, Anna C. Coluccia, Maria C. Di Dedda, Stefano Salvatore , Irene Cetin , Fabio Ghezzi
To assess the long-term efficacy and safety of polydimethylsiloxane injection (Macroplastique", Cogentix Medical, Orangeburg, New York, USA) for the treatment of female stress urinary incontinence (SUI), with a minimum follow-up of 3 years
This is an observational analytical prospective cohort study conducted in a single uro-gynaecological unit. All consecutive women with urodynamically confirmed pure SUI treated with the Macroplastique procedure, were included. Data regarding patient outcomes (International Consultation on Incontinence Questionnaire–Short Form, Patient Global Impression of Improvement, and patient satisfaction scores), objective cure rates, and adverse events were collected during follow-up.
BJU International · September 2018. DOI: 10.1111/bju.14550
Trattamento con Macroplastique: 2 anni di Follow up
2010 - Ghoniem, G., Corcos, J., Comiter, C., Westney, O.L., & Herschorn, S
Durability of urethral bulking agent injecton for female stress urinary incontinence: 2-year multicenter study result.
We evaluated the durability of the urethral bulking agent Macroplastique® for stress urinary incontinence in a 24-month study in women with a previously documented successful outcome 12 months after the last injection.
J Urol, 183, 1444-1449.